Table 2. Shortlisted CTL Epitopes for the Final Vaccine Construction.

epitopes	protein	C-score	immunogenicity score	antigenicity	allergenicity	toxicity	epitope conservancy hit (maximum identity %)	human homology	interacting MHC-I allelesa
GSNDTELNY	L	2.1551	0.13913 (positive)	1.1545 (probable antigen)	probable non-allergen	non-toxin	100	non-homologue	HLA-A*01:01, HLA-B*58:01, HLA-A*30:02
WTIGNRAPY	L	2.4674	0.14626 (positive)	1.2809 (probable antigen)	probable non-allergen	non-toxin	100	non-homologue	HLA-A*26:01, HLA-A*30:02, HLA-A*01:01, HLA-C*03:03, HLA-B*15:01, HLA-B*35:01
FDERRHVAM	NP	2.2254	0.22313 (positive)	0.9841 (probable antigen)	probable non-allergen	non-toxin	100	non-homologue	HLA-B*14:02, HLA-B*08:01, HLA-C*07:02
RPMNRPTAL	NP	1.9018	0.03207 (positive)	0.5629 (probable antigen)	probable non-allergen	non-toxin	100	non-homologue	HLA-B*07:02, HLA-B*08:01, HLA-B*39:01, HLA-B*48:01, HLA-B*14:02, HLA-B*53:01, HLA-B*35:01
NPHAQGIAL	GP	1.5028	0.10415 (positive)	1.0162 (probable antigen)	probable non-allergen	non-toxin	100	non-homologue	HLA-B*39:01, HLA-B*35:01, HLA-B*15:02, HLA-B*07:02
FTYNLTNLV	VP40	1.2927	0.00609 (positive)	0.7288 (probable antigen)	probable non-allergen	non-toxin	100	non-homologue	HLA-A*02:01, HLA-A*68:02, HLA-A*02:06, HLA-A*01:01, HLA-A*26:01, HLA-B*51:01, HLA-C*06:02, HLA-C*15:02, HLA-B*46:01
RTTAPAAAF	VP35	1.4688	0.13388 (positive)	0.4463 (probable antigen)	probable non-allergen	non-toxin	100	non-homologue	HLA-A*32:01, HLA-B*58:01, HLA-B*57:01, HLA-B*07:02, HLA-C*03:03, HLA-B*15:01, HLA-B*35:01
SLTCAGIRK	VP30	1.1697	0.17091 (positive)	1.3530 (probable antigen)	probable non-allergen	non-toxin	100	non-homologue	HLA-A*03:01, HLA-A*11:01
ISPNLLGIY	VP24	1.4959	0.07501 (positive)	1.0528 (probable antigen)	probable non-allergen	non-toxin	100	non-homologue	HLA-A*30:02, HLA-A*01:01, HLA-A*26:01, HLA-B*46:01

^aMHC-I alleles with percentile rank ≤2 were taken.